RecombinantCXCL8(IL-8)
50190P-22ug
50190P-1010ug
50190P-5050ug
50190P-100100ug
50190P-10001000ug
ThesmallcytokineCXCL8(alsoknownasIL-8)isknowntobeoneofthemostpotentchemoattractantmoleculesthat,amongseveralotherfunctions,isresponsIBLeforguidingneutrophilsthroughthetissuematrixuntiltheyreachsitesofinjury.IL-8isalsoapotentpromoterofangiogenesis.Intargetcells,IL-8bindstotwocellsurfacereceptors,CXCR1andCXCR2,andinducesaseriesofphysiologicalresponsesrequiredformigrationandphagocytosis,suchas
increaseofintracellularCa2+,exocytosis(e.g.histaminerelease),andrespiratoryburst.IL-8isa
memberoftheCXCchemokinefamily.ThegenesencodingthisandtheothertenmembersoftheCXCchemokinefamilyformaclusterinaregionmappedtochromosome4q.
Source:RecombinanthumanCXCL8isproducedinE.coli(accessionno.
P10145).
StABIlityandStorage:12monthsfromdateofreceipt,-20oCto-70oC,assupplied.
1month,2oCto8oC,understerileconditionsafterreconstitution.
3months,-20oCto-70oC,understerileconditionsafterreconstitution.
Forinvitroinvestigationaluseonly.Notforuseindiagnosticortherapeuticprocedures.
美国QED Bioscience 公司(www.qedbio.com)是专业的抗体公司,有20年的历史,是世界著名的抗体生产商。QED生物科技为科研客户提供优质的单克隆和多克隆抗体产品。 是一家提供全面服务的并提供额外服务的公司,能提供超过1500的单克隆和多克隆抗体的用于多领域的研究。